SEC Form 4 · accession 0001061983-17-000035
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wendall Wierenga
Director
Period of report
May 18, 2017
Accepted (ET)
May 22, 2017 · 5:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $14.25 | May 18, 2017 | A | 20,000 | A | Jun 18, 2017 | May 18, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 18, 2018.